Published in Lancet on February 13, 1993
Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci U S A (2007) 2.52
Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst (2009) 2.40
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med (2013) 2.30
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int (2011) 2.28
Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut (1995) 2.10
Association of valvular heart disease with Chinese-herb nephropathy. Lancet (1998) 2.07
The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol (2014) 1.70
Chinese slimming capsules containing sibutramine sold over the Internet: a case series. Dtsch Arztebl Int (2009) 1.64
Enhanced evidence-based chinese medicine clinical practice guidelines in Hong Kong: a study protocol for three common diseases. Evid Based Complement Alternat Med (2015) 1.40
Activation of p53 promotes renal injury in acute aristolochic acid nephropathy. J Am Soc Nephrol (2009) 1.24
DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells. Nucleic Acids Res (2009) 1.23
Natural products as starting points for future anti-malarial therapies: going back to our roots? Malar J (2011) 1.22
Chronic kidney disease and cancer: a troubling connection. J Nephrol (2010) 1.18
Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med (2008) 1.15
Perspective: Herbal dangers. Nature (2011) 1.05
Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats. BMC Bioinformatics (2006) 1.02
Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine. Br J Pharmacol (2009) 1.01
An integrated web medicinal materials DNA database: MMDBD (Medicinal Materials DNA Barcode Database). BMC Genomics (2010) 0.97
An epidemiological study of concomitant use of Chinese medicine and antipsychotics in schizophrenic patients: implication for herb-drug interaction. PLoS One (2011) 0.97
Zebrafish heart failure models for the evaluation of chemical probes and drugs. Assay Drug Dev Technol (2013) 0.93
Physiological and molecular characterization of aristolochic acid transport by the kidney. J Pharmacol Exp Ther (2011) 0.92
Balkan endemic nephropathy-current status and future perspectives. Clin Kidney J (2013) 0.91
Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents. Int J Cancer (2010) 0.91
Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol (2009) 0.91
Chemoprevention of bladder cancer. World J Urol (2006) 0.90
Analysis of the adverse reactions induced by natural product-derived drugs. Br J Pharmacol (2010) 0.89
Mutation signatures of carcinogen exposure: genome-wide detection and new opportunities for cancer prevention. Genome Med (2014) 0.89
An integrated system for identifying the hidden assassins in traditional medicines containing aristolochic acids. Sci Rep (2015) 0.89
Toxicity Profile of the Aqueous Ethanol Root Extract of Corrigiola telephiifolia Pourr. (Caryophyllaceae) in Rodents. Evid Based Complement Alternat Med (2010) 0.89
Bioinformatics opportunities for identification and study of medicinal plants. Brief Bioinform (2012) 0.88
An authenticity survey of herbal medicines from markets in China using DNA barcoding. Sci Rep (2016) 0.88
Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol Sci (2011) 0.88
Development of a chronic kidney disease model in C57BL/6 mice with relevance to human pathology. Nephron Extra (2013) 0.88
Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. Toxins (Basel) (2010) 0.88
CKD hotspots around the world: where, why and what the lessons are. A CKJ review series. Clin Kidney J (2014) 0.87
Factors associated with CKD in the elderly and nonelderly population. Clin J Am Soc Nephrol (2012) 0.86
beta-Naphthoflavone protects mice from aristolochic acid-I-induced acute kidney injury in a CYP1A dependent mechanism. Acta Pharmacol Sin (2009) 0.86
The involvement of mycotoxins in the development of endemic nephropathy. Wien Klin Wochenschr (2008) 0.86
Mapping the alternative route. BMJ (2007) 0.85
Chemical Constituents and Pharmacology of the Aristolochia ( mădōu ling) species. J Tradit Complement Med (2012) 0.85
Fanconi's syndrome, interstitial fibrosis and renal failure by aristolochic acid in Chinese herbs. Pediatr Nephrol (2006) 0.85
Observational studies on evaluating the safety and adverse effects of traditional chinese medicine. Evid Based Complement Alternat Med (2013) 0.84
Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers. Support Care Cancer (2008) 0.84
Treatment- and disease-related complications of prostate cancer. Rev Urol (2006) 0.84
Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed Res Int (2013) 0.83
Americans' use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis (2013) 0.83
Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis (2014) 0.83
The molecular mechanism of leptin secretion and expression induced by aristolochic acid in kidney fibroblast. PLoS One (2011) 0.83
Aristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels. Br J Pharmacol (2016) 0.82
Patent applications for using DNA technologies to authenticate medicinal herbal material. Chin Med (2009) 0.82
Chinese herb nephropathy. Proc (Bayl Univ Med Cent) (2000) 0.82
The Potential Power of Bar-HRM Technology in Herbal Medicine Identification. Front Plant Sci (2016) 0.82
Identification of a reduction product of aristolochic acid: implications for the metabolic activation of carcinogenic aristolochic acid. J Nat Prod (2010) 0.81
Aristolochic acid I metabolism in the isolated perfused rat kidney. Chem Res Toxicol (2011) 0.81
Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference. Biomed Res Int (2014) 0.81
Adverse effects from traditional Chinese medicine. Lancet (1993) 0.81
Development of Safe and Effective Botanical Dietary Supplements. J Med Chem (2015) 0.81
Chinese herbal medicines. West J Med (2002) 0.81
«Suspects» in etiology of endemic nephropathy: aristolochic acid versus mycotoxins. Toxins (Basel) (2010) 0.80
Evaluating weight of evidence in the mystery of Balkan endemic nephropathy. Risk Anal (2014) 0.80
Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection. PLoS One (2014) 0.80
A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches. Int J Mol Sci (2015) 0.80
Metabolomic analysis of complex chinese remedies: examples of induced nephrotoxicity in the mouse from a series of remedies containing aristolochic Acid. Evid Based Complement Alternat Med (2013) 0.80
DNA barcoding as a complementary tool for conservation and valorisation of forest resources. Zookeys (2013) 0.80
Mechanisms of enzyme-catalyzed reduction of two carcinogenic nitro-aromatics, 3-nitrobenzanthrone and aristolochic acid I: Experimental and theoretical approaches. Int J Mol Sci (2014) 0.80
Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells. Acta Pharmacol Sin (2010) 0.80
Possible health impacts of naturally occurring uptake of aristolochic acids by maize and cucumber roots: links to the etiology of endemic (Balkan) nephropathy. Environ Geochem Health (2012) 0.80
Can Herbal Medicine Cause Hematoma Enlargement of Hypertensive Intracerebral Hemorrhage within 24 hrs Time Window? A Retrospective Study of 256 Cases from a Single Center in China. Evid Based Complement Alternat Med (2015) 0.80
Safety surveillance of traditional Chinese medicine: current and future. Drug Saf (2015) 0.80
Endemic Nephropathy Around the World. KI Rep (2017) 0.80
An Integrated View of Aristolochic Acid Nephropathy: Update of the Literature. Int J Mol Sci (2017) 0.79
An overview on adverse drug reactions to traditional Chinese medicines. Br J Clin Pharmacol (2015) 0.79
Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid. PLoS One (2014) 0.79
Smad7 protects against chronic aristolochic acid nephropathy in mice. Oncotarget (2015) 0.79
Risk assessment of upper tract urothelial carcinoma related to aristolochic acid. Cancer Epidemiol Biomarkers Prev (2013) 0.79
Sleep disorders. Liver damage warning with insomnia remedy. BMJ (1993) 0.79
Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study. BMJ Open (2014) 0.78
Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants. Clin J Am Soc Nephrol (2015) 0.78
Leveraging biodiversity knowledge for potential phyto-therapeutic applications. J Am Med Inform Assoc (2013) 0.78
Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem Res Toxicol (2014) 0.78
In vivo toxicity evaluation of a standardized extract of Syzygium aqueum leaf. Toxicol Rep (2014) 0.78
Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research. Quant Imaging Med Surg (2015) 0.77
Contribution of biotransformation enzymes to the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions, difficult answers. Interdiscip Toxicol (2008) 0.77
Acute Renal Failure Induced by Chinese Herbal Medication in Nigeria. Case Rep Med (2015) 0.77
Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo. Toxicology (2016) 0.77
Active Site Mutations as a Suitable Tool Contributing to Explain a Mechanism of Aristolochic Acid I Nitroreduction by Cytochromes P450 1A1, 1A2 and 1B1. Int J Mol Sci (2016) 0.77
Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor. Int J Mol Sci (2015) 0.77
Genetic loci that affect aristolochic acid-induced nephrotoxicity in the mouse. Am J Physiol Renal Physiol (2011) 0.77
Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis. Toxicol Rep (2015) 0.77
Aristolochic acid causes albuminuria by promoting mitochondrial DNA damage and dysfunction in podocyte. PLoS One (2013) 0.76
Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells. Carcinogenesis (2016) 0.76
Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Mol Med Rep (2015) 0.76
Herbal supplements: considerations for the athletic trainer. J Athl Train (2001) 0.76
Epidemiology of cancer in end-stage renal disease dialysis patients: a national cohort study in Taiwan. J Cancer (2017) 0.75
Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats. BMC Complement Altern Med (2017) 0.75
Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol (2017) 0.75
Pharmacokinetics of p-Aminohippuric Acid and Inulin in Rabbits with Aristolochic Acid Nephropathy. Adv Pharmacol Sci (2011) 0.75
Biological activity and toxicity of the Chinese herb Magnolia officinalis Rehder & E. Wilson (Houpo) and its constituents. J Zhejiang Univ Sci B (2017) 0.75
Is herbal tea consumption a factor in endemic nephropathy? Eur J Epidemiol (2014) 0.75
The prevalence, characteristics, and factors associated with purchasing Chinese herbal medicine among adults in Taiwan. BMC Complement Altern Med (2017) 0.75
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N Engl J Med (2000) 8.02
Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75
Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med (2000) 5.53
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Kluyvera, a new (redefined) genus in the family Enterobacteriaceae: identification of Kluyvera ascorbata sp. nov. and Kluyvera cryocrescens sp. nov. in clinical specimens. J Clin Microbiol (1981) 3.63
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
Health insurance coverage among foreign-born US residents: the impact of race, ethnicity, and length of residence. Am J Public Health (1997) 3.09
Fibrate-induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent? Nephrol Dial Transplant (2000) 2.99
Bioreactance is not reliable for estimating cardiac output and the effects of passive leg raising in critically ill patients. Br J Anaesth (2013) 2.83
Spleen cell cytokine secretion in Mycobacterium bovis BCG-infected mice. Infect Immun (1992) 2.50
Clinical use of respiratory changes in arterial pulse pressure to monitor the hemodynamic effects of PEEP. Am J Respir Crit Care Med (1999) 2.28
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection. Transplantation (2000) 2.17
Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med (1989) 2.16
Computerized analysis of smooth muscle fibers in potent and impotent patients. J Urol (1991) 2.13
Cardiorespiratory effects of pressure-controlled ventilation with and without inverse ratio in the adult respiratory distress syndrome. Chest (1993) 2.07
Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis (1999) 2.05
Experience with the Wujciak-Opelz allocation system in a single center: an increase in HLA-DR mismatching and in early occurring acute rejection episodes. Transpl Int (1998) 2.00
Investigations on ferroelectric PMN-PT and PZN-PT single crystals ability for power or resonant actuators. Ultrasonics (2004) 1.97
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Expression of Bcl-x in erythroid precursors from patients with polycythemia vera. N Engl J Med (1998) 1.85
Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group. Medicine (Baltimore) (1997) 1.83
Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine. Crit Care Med (1998) 1.83
Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France. J Antimicrob Chemother (1999) 1.71
Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood (1996) 1.68
Lymphoid hypoplasia and somatic cloning. Lancet (1999) 1.68
Thrombotic microangiopathy induced by long-term interferon-β therapy for multiple sclerosis: a case report. Clin Nephrol (2011) 1.64
Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"? Am J Kidney Dis (2001) 1.61
Estimating cardiac filling pressure in mechanically ventilated patients with hyperinflation. Crit Care Med (2000) 1.57
Nosocomial infections by chlorhexidine solution contaminated with Pseudomonas pickettii (Biovar VA-I). J Infect (1983) 1.55
Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial. Ann Intern Med (1999) 1.52
Preferential activation of Th2 cells in chronic graft-versus-host reaction. J Immunol (1993) 1.50
Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) (2007) 1.49
Flavobacterium multivorum septicemia in a hemodialyzed patient. J Clin Microbiol (1984) 1.49
Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant (2000) 1.46
The neurotoxicity and safety of treatment with cefepime in patients with renal failure. Nephrol Dial Transplant (2008) 1.46
Identification of aristolochic acid in Chinese herbs. Lancet (1994) 1.45
Anaphylaxis to pork kidney is related to IgE antibodies specific for galactose-alpha-1,3-galactose. Allergy (2012) 1.43
The predictive value of cardiac troponin T measurements in subjects on regular haemodialysis. Nephrol Dial Transplant (1999) 1.43
[Taxonomic value of beta xylosidase detection in Enterobacteriaceae]. Ann Inst Pasteur (Paris) (1972) 1.41
Pathogenesis of polycythemia vera. Haematologica (1998) 1.41
Amygdaloid projections to ventromedial striatal subterritories in the primate. Neuroscience (2002) 1.40
Kidney graft dysfunction after drug interaction between clarithromycin and cyclosporin. Nephrol Dial Transplant (1996) 1.40
High haematocrit in haemodialysis patients can be controlled by theophylline administration. Nephrol Dial Transplant (1994) 1.40
Splenic lymphoma presenting as necrotizing glomerulonephritis. Clin Nephrol (1998) 1.39
Wave reflection and transmission reduction using a piezoelectric semipassive nonlinear technique. J Acoust Soc Am (2006) 1.39
Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies. Nephrol Dial Transplant (1999) 1.39
Activation of a pro-apoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP. FEBS Lett (2000) 1.38
[Acquired corticotropin insufficiency in adults. 2 new cases]. Rev Med Interne (1993) 1.38
Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors. Nephrol Dial Transplant (1992) 1.38
Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int (1994) 1.38
Systemic release and protective role of IL-10 in staphylococcal enterotoxin B-induced shock in mice. J Immunol (1994) 1.37
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection. J Clin Invest (1999) 1.35
Purification and characterization of the alpha-agarase from Alteromonas agarlyticus (Cataldi) comb. nov., strain GJ1B. Eur J Biochem (1993) 1.34
Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. Transplantation (2000) 1.33
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med (1992) 1.32
Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells. Immunology (1992) 1.32
A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer. Perit Dial Int (1999) 1.32
[Antigenic and biochemical study of 500 Klebsiella strains]. Ann Biol Clin (Paris) (1973) 1.31
Fulminant necrotizing fasciitis and nonsteroidal anti-inflammatory drugs. J Infect Dis (1987) 1.30
Developmental expression of the Arabidopsis thaliana CycA2;1 gene. Planta (2000) 1.29
Brucella endocarditis: the role of combined medical and surgical treatment. Rev Infect Dis (1990) 1.29
HIV infection among women in prison: an assessment of risk factors using a nonnominal methodology. Am J Public Health (1994) 1.27
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
O and H serotyping of Pseudomonas cepacia. J Clin Microbiol (1983) 1.24
c-Myc antagonizes the effect of p53 on apoptosis and p21WAF1 transactivation in K562 leukemia cells. Oncogene (2000) 1.23
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
[Taxonomic study of Levinea, a new genus in the Enterobacteriaceae family]. Ann Inst Pasteur (Paris) (1972) 1.21
Possible role of dialysis membrane characteristics in amyloid osteoarthropathy. Lancet (1986) 1.20
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney Int (2007) 1.19
Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int (1999) 1.17
[Research technics of enzymes used in the diagnosis of gram negative bacteria (author's transl)]. Ann Biol Clin (Paris) (1978) 1.17
Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. Kidney Int (1991) 1.16
[Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)]. Ann Biol Clin (Paris) (1981) 1.15
Max and inhibitory c-Myc mutants induce erythroid differentiation and resistance to apoptosis in human myeloid leukemia cells. Oncogene (1997) 1.15
Hirschsprung's disease associated with congenital heart malformation, broad big toes, and ulnar polydactyly in sibs: a case for fetoscopy. J Med Genet (1975) 1.14
Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis. Nat Genet (1997) 1.11
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil. Ther Drug Monit (2003) 1.10
In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med (1993) 1.10
[Study of Enterobacter strains belonging to a particular group related to Enterobacter aerogenes (author's transl)]. Ann Microbiol (Paris) (1976) 1.09
The Chlamydomonas reinhardtii LI818 gene represents a distant relative of the cabI/II genes that is regulated during the cell cycle and in response to illumination. Plant Mol Biol (1996) 1.09
Beta-2 microglobulin in renal disease. J Am Soc Nephrol (1998) 1.08
[Methodology and practical use in hemodialysis of the percentage of urea reduction (PUR)]. Nephrologie (1995) 1.08
Third-generation FloTrac/Vigileo does not reliably track changes in cardiac output induced by norepinephrine in critically ill patients. Br J Anaesth (2012) 1.07
Tacrolimus combined with two different dosages of sirolimus in kidney transplantation: results of a multicenter study. Am J Transplant (2006) 1.07
Thoughts on the importance of being different. Can Fam Physician (1997) 1.07
Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med (1999) 1.06
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood: II. Application to rheumatoid arthritis and osteoarthritis. Cytokine (1992) 1.06
Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. J Immunol (1990) 1.06
Relapses of lupus nephritis: incidence, risk factors, serology and impact on outcome. Lupus (2003) 1.06
Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (2000) 1.06
[Rapid technics for measuring lysine decarboxylase, ornithine decarboxylase and arginine dihydrolase in the genera Pseudomonas, Alcaligenes and Moraxella]. Ann Inst Pasteur (Paris) (1968) 1.04
Pseudomonas paucimobilis peritonitis in patients treated by peritoneal dialysis. J Clin Microbiol (1984) 1.04
HIV-1 infection in a medium security prison for women--Quebec. Can Dis Wkly Rep (1989) 1.04
Hand transplantation: the state-of-the-art. J Hand Surg Eur Vol (2006) 1.04
Prediction of fluid responsiveness by a continuous non-invasive assessment of arterial pressure in critically ill patients: comparison with four other dynamic indices. Br J Anaesth (2012) 1.03